新闻
2026-11-12
Hinge Bio Shares Encouraging Clinical Data for HB2198, a Novel B-Cell Depleting Agent for Treating Autoimmune Disease, at ACR Convergence 2026
免疫疗法AACR会议
2026-11-12
Merck Announces Positive Results from Phase 2b Trial of Efinopegdutide in Adults with Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Stage 2-3 Fibrosis
临床结果快速通道引进/卖出
2026-11-11
Adneuris Therapeutics Reaches Key Regulatory Milestone with FDA Submission of New Drug Application for Cebranopadol in Moderate-to-Severe Acute Pain
临床结果快速通道
Boehringer Ingelheim's survodutide is the first glucagon/GLP-1 dual agonist to demonstrate a favorable cardiovascular safety profile in global Phase III SYNCHRONIZE-CVOT trial alongside significant cardiometabolic benefits
临床结果快速通道突破性疗法AHA会议
2026-11-10
细胞疗法引进/卖出孤儿药上市批准
2026-11-10
J&J's bispecific combo shows early promise in prostate cancer study
临床结果免疫疗法ASCO会议
2026-11-10
Skyhawk Therapeutics Announces First U.S. Patients Dosed in Pivotal FALCON-HD Study Evaluating SKY-0515 in Huntington’s Disease
2026-11-10
蛋白降解靶向嵌合体
2026-11-10
Marengo Presents Interim Phase 2 STARt-002 Results for First-in-Class Selective T-Cell Agonist Invikafusp Alfa Plus Sacituzumab Govitecan Across Two Metastatic Breast Cancer Cohorts in Oral Presentation at SITC 2026
临床结果免疫疗法快速通道AACR会议
2026-11-10
高管变更并购